This morning, Helus Pharma announced the appointment of Michael Cola as CEO. Here, Psychedelic Alpha’s Josh Hardman speaks with the newly appointed executive in a brief Q&A on execution, regulatory rigour, and scaling serotonergic CNS medicines. Josh Hardman, Psychedelic Alpha: How does your background in specialty pharma support Helus? Michael Cola, Helus: I have spent my career taking…
